Literature DB >> 17396583

Interaction with DNA as a cytotoxicity factor of a novel glycoside derivative of indolocarbazole.

D N Kalyuzhnyi1, V V Tatarskii, F S Bondarev, I L Plikhtyak, T D Miniker, S Y Me'lnik, A A Shtil', O F Borisova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17396583     DOI： 10.1134/s1607672906060111

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  8 in total

1.  [Heterogeneity of strong binding sites of ethidium bromide to DNA. fluorescing and nonfluorescing complexes].

Authors:  O F Borisova; A K Shchelkina; A T Karapetian; A N Surovaia
Journal:  Mol Biol (Mosk)       Date:  1998 Sep-Oct

2.  Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.

Authors:  C Bailly; P Colson; C Houssier; E Rodrigues-Pereira; M Prudhomme; M J Waring
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

3.  Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition.

Authors:  C Bailly; X Qu; D E Graves; M Prudhomme; J B Chaires
Journal:  Chem Biol       Date:  1999-05

4.  DNA sequence recognition by the indolocarbazole antitumor antibiotic AT2433-B1 and its diastereoisomer.

Authors:  Carolina Carrasco; Michaël Facompré; John D Chisholm; David L Van Vranken; W David Wilson; Christian Bailly
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

Review 5.  New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response.

Authors:  Yan Luo; Joel D Leverson
Journal:  Expert Rev Anticancer Ther       Date:  2005-04       Impact factor: 4.512

Review 6.  Biological targets of antitumor indolocarbazoles bearing a sugar moiety.

Authors:  Michelle Prudhomme
Journal:  Curr Med Chem Anticancer Agents       Date:  2004-11

7.  Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue.

Authors:  C Bailly; X Qu; F Anizon; M Prudhomme; J F Riou; J B Chaires
Journal:  Mol Pharmacol       Date:  1999-02       Impact factor: 4.436

8.  DNA binding and topoisomerase I poisoning activities of novel disaccharide indolocarbazoles.

Authors:  Michaël Facompre; Carolina Carrasco; Pierre Colson; Claude Houssier; John D Chisholm; David L Van Vranken; Christian Bailly
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436
  8 in total
  1 in total

1.  Novel Indolocarbazole Derivative 12-(α-L-arabinopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione Is a Preferred c-Myc Guanine Quadruplex Ligand.

Authors:  Dmitry N Kaluzhny; Anna K Shchyolkina; Nikolay S Ilyinsky; Olga F Borisova; Alexander A Shtil
Journal:  J Nucleic Acids       Date:  2011-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.